[Chronic renal insufficiency: from laboratory to clinic]

Area of Science:

• Nephrology
• Pathophysiology
• Molecular Biology

Background:

• Progressive renal scarring involves glomerulosclerosis and tubulo-interstitial fibrosis.
• These fibrotic processes contribute to the decline in renal function.
• Recent research has elucidated the underlying mechanisms of renal scarring.

Discussion:

• Glomerulosclerosis shares similarities with atherosclerosis, implicating growth factors.
• Platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta) are crucial.
• Tubulo-interstitial scarring involves complex cell interactions mediated by growth factors.

Key Insights:

• Growth factors, particularly PDGF and TGF-beta, play a significant role in both glomerulosclerosis and tubulo-interstitial fibrosis.
• Understanding these molecular pathways is essential for comprehending renal scarring progression.
• Therapeutic strategies targeting growth factors are being explored based on experimental findings.

Outlook:

• Experimental insights into growth factor contributions to renal scarring are guiding new therapeutic interventions.
• The clinical efficacy of targeting growth factors for progressive renal scarring requires further investigation.
• Future research will determine if manipulating growth factors benefits patients with kidney scarring.